Qing Yu (Christina) Weng, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Phototherapy | 1 | 2016 | 368 | 0.420 |
Why?
|
| Travel | 1 | 2016 | 805 | 0.340 |
Why?
|
| Ultraviolet Rays | 4 | 2021 | 1104 | 0.340 |
Why?
|
| Patient Compliance | 2 | 2016 | 2701 | 0.320 |
Why?
|
| Melanins | 3 | 2020 | 292 | 0.290 |
Why?
|
| Skin Pigmentation | 2 | 2021 | 281 | 0.200 |
Why?
|
| Microphthalmia-Associated Transcription Factor | 2 | 2021 | 257 | 0.190 |
Why?
|
| Pigmentation Disorders | 1 | 2020 | 105 | 0.160 |
Why?
|
| Histocompatibility Antigens | 1 | 2020 | 479 | 0.160 |
Why?
|
| Health Services Accessibility | 1 | 2016 | 5522 | 0.150 |
Why?
|
| Histone Deacetylases | 1 | 2020 | 718 | 0.130 |
Why?
|
| Dermatologic Agents | 1 | 2020 | 313 | 0.130 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2020 | 701 | 0.120 |
Why?
|
| Cellulitis | 1 | 2017 | 206 | 0.120 |
Why?
|
| Oncogenes | 1 | 2020 | 1236 | 0.110 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2020 | 1803 | 0.110 |
Why?
|
| Hyperkalemia | 1 | 2015 | 234 | 0.110 |
Why?
|
| Breast Implantation | 1 | 2015 | 225 | 0.100 |
Why?
|
| Appointments and Schedules | 1 | 2016 | 443 | 0.100 |
Why?
|
| Skin | 2 | 2017 | 4506 | 0.100 |
Why?
|
| Spironolactone | 1 | 2015 | 415 | 0.100 |
Why?
|
| Potassium | 1 | 2015 | 1315 | 0.090 |
Why?
|
| Acne Vulgaris | 1 | 2015 | 352 | 0.090 |
Why?
|
| Surgery, Plastic | 1 | 2015 | 651 | 0.070 |
Why?
|
| Monitoring, Physiologic | 1 | 2015 | 1798 | 0.070 |
Why?
|
| Melanocytes | 2 | 2021 | 509 | 0.070 |
Why?
|
| Skin Diseases | 1 | 2016 | 1085 | 0.070 |
Why?
|
| Epigenesis, Genetic | 1 | 2020 | 3836 | 0.070 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2020 | 4651 | 0.070 |
Why?
|
| Cyclic AMP | 2 | 2021 | 1469 | 0.070 |
Why?
|
| Mastectomy | 1 | 2015 | 1850 | 0.070 |
Why?
|
| Dermatology | 1 | 2016 | 905 | 0.060 |
Why?
|
| Mammaplasty | 1 | 2015 | 1263 | 0.060 |
Why?
|
| Patient Care Team | 1 | 2015 | 2528 | 0.050 |
Why?
|
| Medical Oncology | 1 | 2015 | 2350 | 0.050 |
Why?
|
| Melanoma | 1 | 2021 | 5709 | 0.050 |
Why?
|
| Melanosomes | 1 | 2021 | 34 | 0.050 |
Why?
|
| Monophenol Monooxygenase | 1 | 2021 | 72 | 0.050 |
Why?
|
| Core Binding Factor Alpha 3 Subunit | 1 | 2020 | 58 | 0.040 |
Why?
|
| Phenylenediamines | 1 | 2020 | 89 | 0.040 |
Why?
|
| Lymphocytic choriomeningitis virus | 1 | 2020 | 176 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2017 | 15951 | 0.040 |
Why?
|
| Acrylamides | 1 | 2020 | 261 | 0.040 |
Why?
|
| Delivery of Health Care | 1 | 2016 | 5375 | 0.040 |
Why?
|
| Administration, Cutaneous | 1 | 2020 | 716 | 0.040 |
Why?
|
| Acetylation | 1 | 2020 | 1056 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 3 | 2021 | 22379 | 0.030 |
Why?
|
| Ubiquitin | 1 | 2021 | 843 | 0.030 |
Why?
|
| Leukocytosis | 1 | 2017 | 251 | 0.030 |
Why?
|
| Lysine | 1 | 2020 | 1000 | 0.030 |
Why?
|
| Administration, Topical | 1 | 2017 | 704 | 0.030 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2020 | 778 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2021 | 2226 | 0.030 |
Why?
|
| Retrospective Studies | 4 | 2016 | 81903 | 0.030 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2021 | 1320 | 0.030 |
Why?
|
| Antigens | 1 | 2020 | 1444 | 0.030 |
Why?
|
| Tachycardia | 1 | 2017 | 599 | 0.030 |
Why?
|
| Tanning | 1 | 2014 | 12 | 0.030 |
Why?
|
| Time Factors | 1 | 2016 | 40261 | 0.030 |
Why?
|
| Epitopes | 1 | 2021 | 2529 | 0.030 |
Why?
|
| Receptor, Melanocortin, Type 1 | 1 | 2014 | 74 | 0.030 |
Why?
|
| Antigens, Neoplasm | 1 | 2021 | 2001 | 0.030 |
Why?
|
| Protein Kinases | 1 | 2020 | 1611 | 0.030 |
Why?
|
| Leg | 1 | 2017 | 1089 | 0.020 |
Why?
|
| DNA Damage | 1 | 2021 | 2472 | 0.020 |
Why?
|
| Humans | 11 | 2021 | 768970 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2014 | 23653 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2021 | 3726 | 0.020 |
Why?
|
| Necrosis | 1 | 2015 | 1620 | 0.020 |
Why?
|
| Emergencies | 1 | 2017 | 1221 | 0.020 |
Why?
|
| Animals | 5 | 2021 | 169335 | 0.020 |
Why?
|
| Bacteremia | 1 | 2017 | 985 | 0.020 |
Why?
|
| Histones | 1 | 2020 | 2603 | 0.020 |
Why?
|
| Zebrafish | 1 | 2021 | 3037 | 0.020 |
Why?
|
| Diagnostic Errors | 1 | 2017 | 1281 | 0.020 |
Why?
|
| Health Resources | 1 | 2016 | 951 | 0.020 |
Why?
|
| Prosthesis-Related Infections | 1 | 2015 | 497 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 2020 | 5505 | 0.020 |
Why?
|
| Base Sequence | 1 | 2020 | 12430 | 0.020 |
Why?
|
| Lymph Nodes | 1 | 2020 | 3473 | 0.020 |
Why?
|
| Mice | 3 | 2021 | 82072 | 0.020 |
Why?
|
| Drug Delivery Systems | 1 | 2020 | 2238 | 0.020 |
Why?
|
| Mitochondria | 1 | 2021 | 3682 | 0.020 |
Why?
|
| Cooperative Behavior | 1 | 2015 | 1515 | 0.020 |
Why?
|
| Middle Aged | 3 | 2017 | 223737 | 0.020 |
Why?
|
| Cell Line | 1 | 2021 | 15604 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2020 | 7609 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2021 | 12806 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2014 | 1966 | 0.020 |
Why?
|
| Breast | 1 | 2015 | 1976 | 0.020 |
Why?
|
| Surgical Wound Infection | 1 | 2015 | 1547 | 0.020 |
Why?
|
| Female | 4 | 2017 | 397515 | 0.010 |
Why?
|
| Models, Theoretical | 1 | 2017 | 3580 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2020 | 14484 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2017 | 9565 | 0.010 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2014 | 2960 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2020 | 17173 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2015 | 8559 | 0.010 |
Why?
|
| Patient Selection | 1 | 2015 | 4265 | 0.010 |
Why?
|
| Mutation | 2 | 2020 | 30266 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2015 | 9684 | 0.010 |
Why?
|
| Phenotype | 1 | 2020 | 16731 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2021 | 16053 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2017 | 14752 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2017 | 13021 | 0.010 |
Why?
|
| Male | 2 | 2017 | 365203 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2017 | 15471 | 0.010 |
Why?
|
| Comorbidity | 1 | 2015 | 10592 | 0.010 |
Why?
|
| Logistic Models | 1 | 2015 | 13318 | 0.010 |
Why?
|
| Age Factors | 1 | 2017 | 18435 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2021 | 18068 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2021 | 41808 | 0.010 |
Why?
|
| Prevalence | 1 | 2015 | 15879 | 0.010 |
Why?
|
| Smoking | 1 | 2015 | 9094 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2017 | 26395 | 0.010 |
Why?
|
| Skin Neoplasms | 1 | 2014 | 5864 | 0.010 |
Why?
|
| Obesity | 1 | 2015 | 13091 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2015 | 15889 | 0.010 |
Why?
|
| Young Adult | 1 | 2015 | 60131 | 0.000 |
Why?
|
| Risk Factors | 1 | 2015 | 74976 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 2015 | 65480 | 0.000 |
Why?
|
| Breast Neoplasms | 1 | 2015 | 21188 | 0.000 |
Why?
|
| United States | 1 | 2015 | 73186 | 0.000 |
Why?
|
| Adolescent | 1 | 2015 | 89244 | 0.000 |
Why?
|
| Aged | 1 | 2017 | 171786 | 0.000 |
Why?
|
| Adult | 1 | 2015 | 223851 | 0.000 |
Why?
|